Computed Drug–Indication Atlas logo
MBRS Bio Terminal
Dashboard • account required (locked) • Email sign-in required
Query MBRS Bio Functions
Interaction
Find biology-vs-expectation gaps and catalyst risk.
How should this user interact with the data?
Choose a mode. Switching later keeps the open tabs from the other mode intact.
Search assets, companies, indications, or type a BIO function…
Low
High
C
H
I
Asset / Indication
Headline
MBRS
Bio
Rank
Compass
Combo
Status
C
H
I
AJ1-11095 1171 → Post Polycythaemia Vera Myelofibrosis
Open · Historical graphs · Insight
UNFAVORABLE
0.42
0.50
0.50
3 / 6
0.24
1.00
C
H
I
AJ1-11095 438 → Polycythemia Vera
Open · Historical graphs · Insight
UNFAVORABLE
0.42
0.51
0.51
9 / 9
0.20
0.91
C
H
I
Fulvestrant → Breast Cancer
Open · Historical graphs · Insight
UNFAVORABLE
0.61
0.64
0.64
2 / 14
0.58
0.67
C
H
I
NVP-LDE225 → Idiopathic Myelofibrosis
Open · Historical graphs · Insight
UNFAVORABLE
0.53
0.56
0.56
5 / 15
0.49
0.71
Access MBRS Bio Terminal

Biology is the only determinant of outcome that surfaces asset-indication differentiation, mispricing and landscape shifts. View Biotech and Pharma asset risk through the lens of Biology.

Entry
Email sign-in is required before any dashboard access. New accounts enter the limited MBRS dashboard first, while full MBRS access remains locked until you approve subscription access after payment terms are agreed.
Full MBRS Bio Terminal
Upgrade requests go to the access page. A user can have a basic email account first, but the full database gateway is only enabled after admin approval.
Request subscription access
Logout clears every MBRS auth/session key. Google/Microsoft buttons now use Supabase OAuth and remember the session in this browser.